Ingen internetforbindelse — viser den gemte version af siden.

Revvity Inc.

USUSD
← Til Screeneren

Revvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Antal børser, hvor selskabets aktier handles: 3. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
revvity.com
Sektor
Industrials · Biotechnology: Laboratory Analytical Instruments
Hovedkontor
Waltham, United States
Administrerende Direktør
Prahlad R. Singh
Ansatte
11 000
Udestående Aktier
111.59 mio. pr. 2026-08-06
Free Float
102.49 mio.
Markedsværdi
16.63 mia. USD
Insidere
0.26%
Institutionelle Investorer
96.55%
Branche (SIC)
Laboratory Analytical Instruments
Juridisk Form
ZJTK
LEI
549300IKL1SDPFI7N655
Udbetalingsgrad
13.4%
FCF
558 mio. USD
6%
Gæld
3.21 mia. USD
3.9 år FCF
Udbyttestreak
43 år
Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 05.07.2026 (selskabets seneste rapport).
Beskrivelse

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksRVTY primærUSD154.18 +1.33%almindelige aktier
LSE London Stock Exchange0KHE IOBUSD151.34 +0.00%almindelige aktier
XETRA XetraPKN sekundærEUR136.5 +0.18%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Næste ex-dato: 2026-10-23 · 0.07 USD (US:RVTY)
Pr. År, US:RVTY: 0.28 USD (4 udb.)

Revvity Inc. (RVTY) udbetaler udbytte kvartalsvis. Pr. År (12 måneder op til og med den senest annoncerede betaling): 0.28 USD pr. Aktie (betalinger: 4). Det svarer til cirka 0.18% af den nuværende aktiekurs. Den næste ex-udbyttedato er 23.10.2026: 0.07 USD pr. Aktie, betalt den 13.11.2026. Uafbrudt udbyttehistorik: 43 år.

Ex-DatoUdbetalingBeløb%TypeTicker
2026-10-23 annonceret2026-11-130.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2026-07-172026-08-070.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2026-04-172026-05-080.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2026-01-162026-02-060.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2025-10-172025-11-070.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2025-07-182025-08-080.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2025-04-172025-05-090.0700 USD0.0/0.2 %kvartalsvisUS:RVTY
2025-01-172025-02-070.0700 USD0.0/≈0.2 %kvartalsvisUS:RVTY
2024-10-182024-11-080.0700 USD0.0/≈0.2 %kvartalsvisUS:RVTY
2024-07-192024-08-090.0700 USD0.0/≈0.2 %kvartalsvisUS:RVTY

Nyheder Denne Uge

Pressemeddelelser fra virksomhedens investorhjemmeside, opdateret dagligt. Links fører til virksomhedens hjemmeside. Overskrifterne er på originalsproget, som på virksomhedens hjemmeside.

annonce

Største Ejere

EjerAndelAktierRapportdato
T. Rowe Price Investment…16.37%18.26 mio.2026-06-30
T. ROWE PRICE CAPITAL AP…10.2%11.38 mio.2026-06-30
Jupiter Topco LLC7.74%8.64 mio.2026-06-30
Edgepoint Investment Gro…7.66%8.54 mio.2026-06-30
Blackrock Inc.6.86%7.66 mio.2026-06-30
Vanguard Capital Managem…6.54%7.3 mio.2026-06-30
JANUS INVESTMENT FUND-Ja…5.15%5.75 mio.2026-06-30
Price (T.Rowe) Associate…4.96%5.53 mio.2026-06-30
Vanguard Portfolio Manag…4.28%4.77 mio.2026-06-30
State Street Corporation3.89%4.34 mio.2026-06-30
Victory Capital Manageme…3.27%3.65 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%3.55 mio.2026-06-30
Dimensional Fund Advisor…3.07%3.43 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%2.89 mio.2026-06-30
-Price (T.Rowe) U.S. Val…2.41%2.69 mio.2026-06-30
TR PRICE-Price (T.Rowe)…2.41%2.69 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.29%2.56 mio.2026-06-30
JNL Series Trust-JNL/T.…2.27%2.53 mio.2026-06-30
Victory Portfolios-Victo…2.12%2.37 mio.2026-06-30
T. Rowe Price Value Fund…1.93%2.16 mio.2026-06-30
Invesco Exchange-Traded…1.67%1.87 mio.2026-08-31
SINGH PRAHLAD R (Chief E…≈0.09%105 6762026-08-13
GOLDBERG JOEL S (General…≈0.09%105 2232026-08-14
BARRETT PETER (Director)≈0.03%28 2932026-05-07
WITNEY FRANKLIN R. PH.D.…≈0.02%23 3542026-05-07
CHAPIN SAMUEL R. (Direct…≈0.02%22 6762026-05-07
VICTOR MIRIAME (Officer)≈0.02%18 1222026-02-24
WITZ PASCALE (Director)≈0.01%15 9852026-05-07
KRAKOWIAK MAXWELL (Chief…≈0.01%14 7812026-09-21
MICHAS ALEXANDROS P (Dir…——2026-08-25
MICHAS ALEXIS P (Directo…——2025-08-27